Floatz logo

Deoxycholic Acid

Ovarian Serous Adenocarcinoma

THERAPIM PTY LTDSmall moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

89 Active assets in the Ovarian Serous Adenocarcinoma cohort.

Asset / SponsorPhaseRating
Carboplatin
National Cancer Institute (NCI)
Phase 3BBB
Olaparib
Institute of Cancer Research, United Kingdom
Phase 3BB
Letrozole
Memorial Sloan Kettering Cancer Center
Phase 3BB
Adriamycin
National Cancer Institute (NCI)
Phase 3BB
Cyclophosphamide
Roswell Park Cancer Institute
Phase 2BB

View all 50 →

Same molecule, other indications

Deoxycholic Acid is also rated in:

obesity disorderDormant
BBB
Indicative · Phase 4
73 / 100
View asset →
primary peritoneal carcinomaActive
CC
Indicative · Phase 1/2
45 / 100
View asset →
fallopian tube cancerActive
CC
Indicative · Phase 1/2
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →